Pu, Hong
Heighes, Philippa T.
Simpson, Fiona
Wang, Yaoli
Liang, Zeping
Wischmeyer, Paul
Hugh, Thomas J.
Doig, Gordon S.
Article History
Received: 15 May 2020
Accepted: 22 February 2021
First Online: 23 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: <i>Drs</i>. <i>Pu</i>, <i>Heighes</i>, <i>Simpson</i>, <i>Wang</i>, <i>Hugh</i>, and <i>Ms</i>. <i>Liang</i> reported no funding conflicts. <i>Dr. Doig</i> reported receiving academic research grants related to nutrition in critical illness from the Australian National Health and Medical Research Council, Fresenius Kabi Deutschland GmbH, and Baxter Healthcare Pty Ltd and speakers honoraria from Fresenius Kabi Deutschland GmbH; Baxter Healthcare Australia, Pty Ltd; Nestle Healthcare, Vevy, Switzerland; and Nutricia Pharmaceutical (Wuxi) Co., Ltd. China. <i>Dr</i>. <i>Wischmeyer</i> reported receiving grant funding related to Improving Nutrition Delivery in Acute Illness from the National Institute of Health National Heart, Lung, and Blood Institute R34 HL109369; Canadian Institutes of Health Research; Baxter; Fresenius; Lyric Pharmaceuticals; Isomark, Inc.; and Medtronics. He served as a consultant on Improving Nutrition Care in Intensive Care Unit (ICU) and Perioperative Medicine to Nestle, Abbott, Fresenius, Baxter, Medtronics, Nutricia, and Lyric Pharmaceuticals, and Takeda for research related to this work. He received honoraria or travel expenses for lectures on improving nutrition care in illness from Abbott, Fresenius, and Medtronics.